Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?
作者信息
Azad Rajvardhan, Dave Vivek, Jalali Subhadra
出版信息
Indian J Ophthalmol. 2011 Nov-Dec;59(6):421-2. doi: 10.4103/0301-4738.86305.
Abstract
摘要
相似文献
1
Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?玻璃体内抗血管内皮生长因子的应用：早产儿视网膜病变外科医生面临哈姆雷特式困境？
Indian J Ophthalmol. 2011 Nov-Dec;59(6):421-2. doi: 10.4103/0301-4738.86305.
2
REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY: A Multicenter Study.用于早产儿视网膜病变玻璃体腔内抗血管内皮生长因子注射的32G短针使用安全性报告：一项多中心研究
Retina. 2018 Jun;38(6):1251-1255. doi: 10.1097/IAE.0000000000002172.
3
Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.玻璃体内注射贝伐单抗治疗早产儿视网膜病变：知情同意的考量
Can J Ophthalmol. 2015 Dec;50(6):409-12. doi: 10.1016/j.jcjo.2015.10.004.
4
Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.玻璃体内注射抗血管内皮生长因子治疗早产儿视网膜病变后持续存在的血管造影异常
JAMA Ophthalmol. 2018 Apr 1;136(4):436-437. doi: 10.1001/jamaophthalmol.2017.4172.
5
What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?玻璃体内注射贝伐单抗治疗早产儿视网膜病变的最佳剂量是多少？
Acta Ophthalmol. 2013 Mar;91(2):e154. doi: 10.1111/j.1755-3768.2012.02552.x. Epub 2012 Sep 19.
6
Retrolental Hemorrhage in Berger's Space After Intravitreal Bevacizumab Injection for Retinopathy of Prematurity.早产儿视网膜病变玻璃体内注射贝伐单抗后 Berger 间隙视网膜下出血。
J Pediatr Ophthalmol Strabismus. 2020 Oct 20;57:e71-e73. doi: 10.3928/01913913-20200817-02.
7
Late-onset tractional fibrovascular proliferation post-intravitreal bevacizumab following treatment of retinopathy of prematurity.早产儿视网膜病变治疗后玻璃体内注射贝伐单抗引起的迟发性牵拉性纤维血管增生
Can J Ophthalmol. 2018 Jun;53(3):e99-e103. doi: 10.1016/j.jcjo.2017.09.028. Epub 2017 Dec 16.
8
A new syringe adaptor for intravitreal injection of premature eye.
Retina. 2013 Apr;33(4):889-90. doi: 10.1097/IAE.0b013e318285ce31.
9
How Does the Standard of Care Evolve? Anti-Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example.医疗护理标准是如何演变的？以早产儿视网膜病变治疗中抗血管内皮生长因子药物为例。
Ophthalmology. 2018 Oct;125(10):1485-1487. doi: 10.1016/j.ophtha.2018.04.018.
10
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab.注射雷珠单抗28个月后早产儿视网膜病变复发
Ophthalmol Retina. 2019 Oct;3(10):913-915. doi: 10.1016/j.oret.2019.06.017. Epub 2019 Jul 9.
引用本文的文献
1
Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity.补充叶酸可抑制早产儿增殖性视网膜病变。
Biomolecules. 2025 Feb 19;15(2):309. doi: 10.3390/biom15020309.
2
Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity.早产儿 I 期视网膜病变中 ω-3/ω-6 长链脂肪酸失衡。
Nutrients. 2022 Mar 23;14(7):1333. doi: 10.3390/nu14071333.
3
Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity.血清血管内皮生长因子及其受体水平在早产儿视网膜病变中的作用
Iran J Pediatr. 2015 Aug;25(4):e2373. doi: 10.5812/ijp.2373. Epub 2015 Aug 24.
本文引用的文献
1
Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.贝伐单抗时代的早产儿视网膜病变：将BEAT-ROP研究结果纳入临床实践
Ophthalmology. 2011 Jul;118(7):1227-8. doi: 10.1016/j.ophtha.2011.04.028.
2
Bevacizumab for retinopathy of prematurity.贝伐单抗用于早产儿视网膜病变
N Engl J Med. 2011 Jun 16;364(24):2359; author reply 2361-2. doi: 10.1056/NEJMc1103460.
3
Bevacizumab for retinopathy of prematurity.贝伐单抗用于早产儿视网膜病变。
N Engl J Med. 2011 Jun 16;364(24):2359-60; author reply 2361-2. doi: 10.1056/NEJMc1103460.
4
Bevacizumab for retinopathy of prematurity.贝伐单抗用于早产儿视网膜病变
N Engl J Med. 2011 Jun 16;364(24):2360; author reply 2361-2. doi: 10.1056/NEJMc1103460.
5
Bevacizumab for retinopathy of prematurity.贝伐单抗用于早产儿视网膜病变
N Engl J Med. 2011 Jun 16;364(24):2360-1; author reply 2362. doi: 10.1056/NEJMc1103460.
6
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.玻璃体内注射贝伐单抗治疗 3 期及以上早产儿视网膜病变的疗效。
N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.
7
Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2.基于方案的 1 区早产儿视网膜病变管理的结果：印度双子城 ROP 筛查计划报告号 2。
Am J Ophthalmol. 2011 Apr;151(4):719-724.e2. doi: 10.1016/j.ajo.2010.10.007. Epub 2011 Jan 22.
8
Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia.在局部麻醉下激光治疗早产儿急性视网膜病变的技术方面。
Indian J Ophthalmol. 2010 Nov-Dec;58(6):509-15. doi: 10.4103/0301-4738.71689.
9
Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity.辅助玻璃体内注射贝伐单抗治疗早产儿后部进展性视网膜病变后脉络膜破裂。
J Perinatol. 2010 Jul;30(7):497-9. doi: 10.1038/jp.2009.166.
10
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.CONSORT 2010 声明：平行组随机试验报告的更新指南。
Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
Zotero 插件